About the study
The COVID-19 Clinical Neuroscience Study is a £2.3 million UKRI study jointly led by researchers at the University of Liverpool and King's College London.
Acute neurological and neuropsychiatric complications of COVID-19 affect up to 20-30% of hospitalised patients. In collaboration with CoroNerve and ISARIC-4C study, we will identify these patients, and those that have received the COVID-19 vaccination, and invite them to join COVID-CNS, part of the COVID-19 section of the NIHR BioResource.
